Trivitron Healthcare’s contribution for the detection of Omicron Variants BF.7 and XBB Trivitron’s R&D conducted an in-silico analysis of mutations of the SARS-CoV-2 virus, ensuring Trivitron’s COVID-19 testing…
Mylab to scale up production of COVID-19 testing kits with funding from DBT Currently, Mylab has a manufacturing capacity of 2,00,000 RT-PCR and 50,000 RNA tests Pune-based Mylab Discovery Solutions has…
The impact of COVID-19 on the Indian healthcare industry Charu Sehgal, Partner & Leader, Lifesciences and Healthcare, Deloitte India and Arun Laxminarayanan, Partner, Deloitte speak…
Mylab partners with Adar Poonawalla, CEO, Serum India, Abhijit Pawar, Chairman, APG The partnership will help scale up operations, escalate faster delivery of testing kits for COVID-19